At the San Antonio Breast Cancer Symposium in 2025. We saw the results of the lidERA study, which looked at the oral SERD ...

Organoids are three-dimensional miniature models of organs, grown in a dish. They have become a valuable tool for studying ...

And so we really need more research into how to optimize these patients long-term, especially when we generally do not use menopausal hormone therapy in hormone receptor positive breast cancer.

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

Researchers from the University of Seville have participated in research to identify the molecular details of the regulation of an enzyme essential for sugar metabolism and closely linked to cell ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...